Article Details

Vera Therapeutics Launches with $80 Million Series C Financing to Develop Phase 2b Novel ...

Retrieved on: 2021-01-19 08:15:00

Tags for this article:

Click the tags to see associated articles and topics

Vera Therapeutics Launches with $80 Million Series C Financing to Develop Phase 2b Novel .... View article details on hiswai:

Excerpt

... LLC, Surveyor Capital (a Citadel company), Octagon Capital, Kleiner Perkins, GV (formerly Google Ventures), and Alexandria Venture Investments.

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up